Important Benefits of EBUS-TBNA in Assessing PD-L1 Expression in NSCLC

被引：0
|
作者：
Centanaro, Gianna Vargas [1 ]
Forcen, Elena [1 ]
Morales, Beatriz [1 ]
Alvarez-Sala, J. L. [1 ]
Calle, Myriam [1 ]
Bernabe, M. Jose [1 ]
机构：
[1] Hosp Clin San Carlos, Madrid, Spain
来源：
EUROPEAN RESPIRATORY JOURNAL | 2020年 / 56卷
关键词：
Lung cancer; Bronchoscopy; Lung cancer - diagnosis;
D O I：
10.1183/13993003.congress-2020.1695
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
1695
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Correlation of programmed death-ligand 1 (PD-L1) expression in lung cancer between endobronchial ultrasound-guided transbronchial needle aspiration(EBUS-TBNA) samples and histological specimens
    Guevara Velazquez, Virginia
    Cordovilla Perez, Rosa
    Parra, Carmen
    Rodriguez Gonzalez, Marta
    Bellido, Lorena
    Garcia Garcia, Ruth
    Lopez Zubizarreta, Marco
    Jodra Sanchez, Soraya
    Hernandez Mezquita, Miguel Angel
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [22] PD-L1 expression as a predictor of postoperative recurrence and the association between the PD-L1 expression and EGFR mutations in NSCLC
    Kojima, Kensuke
    Sakamoto, Tetsuki
    Kasai, Takahiko
    Kagawa, Tomoko
    Yoon, Hyungeun
    Atagi, Shinji
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [23] PD-L1 expression as a predictor of postoperative recurrence and the association between the PD-L1 expression and EGFR mutations in NSCLC
    Kensuke Kojima
    Tetsuki Sakamoto
    Takahiko Kasai
    Tomoko Kagawa
    Hyungeun Yoon
    Shinji Atagi
    Scientific Reports, 11
  • [24] Heterogeneity analysis of PD-L1 expression and copy number status in EBUS-TBNA biopsy specimens of non-small cell lung cancer: Comparative assessment of primary and metastatic sites
    Yoshimura, Katsuhiro
    Inoue, Yusuke
    Karayama, Masato
    Tsuchiya, Kazuo
    Mori, Kazutaka
    Suzuki, Yuzo
    Iwashita, Yuji
    Kahyo, Tomoaki
    Kawase, Akikazu
    Tanahashi, Masayuki
    Ogawa, Hiroshi
    Yokomura, Koushi
    Inui, Naoki
    Funai, Kazuhito
    Shinmura, Kazuya
    Niwa, Hiroshi
    Suda, Takafumi
    Sugimura, Haruhiko
    LUNG CANCER, 2019, 134 : 202 - 209
  • [25] PD-L1 expression and efficacy of pembrolizumab as monotherapy in NSCLC
    Jorgensen, Jan Trost
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (04)
  • [26] Usefulness of EBUS-TBNA in the diagnostics of stage 1 and 2 sarcoidosis
    Kalicka, Agata
    Rybacki, Cezary
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [27] Heterogeneity of PD-L1 Expression and Relationship with Biology of NSCLC
    Bassanelli, Maria
    Sioletic, Stefano
    Martini, Maurizio
    Giacinti, Silvana
    Viterbo, Antonella
    Staddon, Anita
    Liberati, Fabrizio
    Ceribelli, Anna
    ANTICANCER RESEARCH, 2018, 38 (07) : 3789 - 3796
  • [28] Clinicopathologic values of PD-L1 expression and polymorphism in NSCLC
    Kim, K. -H.
    VIRCHOWS ARCHIV, 2017, 471 : S110 - S111
  • [29] PD-L1 Expression is Related to Tumor Staging in NSCLC
    Wang, Hangjun
    Agulnik, Jason
    Kasymjanova, Goulnar
    Wang, Anna Y.
    Cohen, Victor
    Small, David
    Pepe, Carmela
    Sakr, Lama
    Fiset, Pierre O.
    Auger, Manon
    Camilleri-Broet, Sophie
    Alameldin, Mona
    Chong, George
    van Kempen, Leon
    Spatz, Alan
    LABORATORY INVESTIGATION, 2018, 98 : 755 - 755
  • [30] PD-L1 Expression is Related to Tumor Staging in NSCLC
    Wang, Hangjun
    Agulnik, Jason
    Kasymjanova, Goulnar
    Wang, Anna Y.
    Cohen, Victor
    Small, David
    Pepe, Carmela
    Sakr, Lama
    Fiset, Pierre O.
    Auger, Manon
    Camilleri-Broet, Sophie
    Alameldin, Mona
    Chong, George
    van Kempen, Leon
    Spatz, Alan
    MODERN PATHOLOGY, 2018, 31 : 755 - 755
12345